Research Impact Award Finalists
This award recognises an individual or team who have demonstrated excellence in the translation of research in any and all forms, which may include products, services, policy reform, new companies including social enterprise that are demonstrably delivering significant impact and benefits for industry and/or broader society and community. This may include social, economic, cultural and/or environmental impact.
The NSW Pharmacist Prescribing Research Team
Associate Professor Sarah Dineen-Griffin, Sarah Taylor, Kristin Xenos, Mitchell Budden, Abeer Ellabaan
The NSW Pharmacist Prescribing Research Team delivered one of Australia’s most significant examples of pharmacy research translation. Through the design, implementation and evaluation of statewide pharmacist prescribing trials, the team generated evidence that informed major healthcare policy reform and expanded pharmacists’ scope of practice in New South Wales. Their work has improved access to timely treatment, strengthened primary healthcare capacity and created a scalable model for future workforce and health system reform. The success and impact of the NSW Pharmacist Prescribing Research Team has been strengthened by the contributions of Professor Shalom (Charlie) Benrimoj, Simone Diamandis and Dr Francisco Martinez Mardones. Their expertise, leadership and commitment have been instrumental in advancing the research, and the team gratefully acknowledges their contributions to this achievement.
Name.Narrate.Navigate (NNN) Program
Professor Tamara Blakemore, Louise Rak, Dr Shaun McCarthy, Associate Professor Sally Hunt, Dr Christoher Krogh, Daniel Ebbin, Nic Thompson
Name.Narrate.Navigate (NNN) is redefining what real-world research from a regional university can look like, and how far its impact can reach. A trauma-informed, culturally responsive program for young people who use and experience violence, and the practitioners who support them, NNN has reached over 500 young people and more than 3,000 practitioners and grown from $20,000 in seed funding to $6.5 million, showing that research built with community, rather than about it, can change how a sector works.
Cancer Signalling Research Group (CSRG)
Professor Matthew Dun, Dr Evangeline Jackson, Quang Anh Tuan Vo, Mika Persson, Florence Bartlett, Dr Tabitha McLachlan, Alicia Douglas, Holly McEwen, Izac Findlay, Jasmine Cairney, Abdul Mannan, Dr Jennifer Coleman, Dr Madeline King, Madi Riley, Marissa Lally, Dr Mark Marsland, Ranjith Jayaraman, Tyrone Sanaila Beitaki, Dr Zac Germon
The Cancer Signalling Research Group (CSRG) has delivered world-leading discoveries that are transforming outcomes for children diagnosed with diffuse midline glioma (DMG/DIPG), one of the most aggressive and fatal childhood brain cancers. The group has built a translational pipeline from laboratory discovery to clinical trials, changing the treatment landscape for a disease that, until recently, had no approved systemic therapy.
The University of Newcastle acknowledges the traditional custodians of the lands within our footprint areas: Awabakal, Darkinjung, Biripai, Worimi, Wonnarua, and Eora Nations. We also pay respect to the wisdom of our Elders past and present.
